Detection of mutations in the apolipoprotein CII gene by denaturing gradient gel electrophoresis. Identification of the splice site variant apolipoprotein CII-Hamburg in a patient with severe hypertriglyceridemia

Clinical Chemistry

Volumn 44, Issue 7, 1998, Pages 1388-1396

  Nauck, Markus S ^a,g   Nissen, Henrik ^b   Hoffmann, Michael M ^a   Herwig, Jürgen ^c   Pullinger, Clive R ^d   Averna, Maurizio ^e   Geisel, Jürgen ^f   Wieland, Heinrich ^a   März, Winfried ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

^b ODENSE UNIVERSITY HOSPITAL   (Denmark)

^c GOETHE UNIVERSITY   (Germany)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e UNIVERSITY OF PALERMO   (Italy)

^f Universitatskliniken des Saarlades   (Germany)

^g UNIVERSITY OF FREIBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN; APOLIPOPROTEIN C2; CHOLESTEROL; LIPID; LIPOPROTEIN; TRIACYLGLYCEROL;

ARTICLE; CASE REPORT; CHILD; CLINICAL FEATURE; DENATURING GRADIENT GEL ELECTROPHORESIS; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; DNA SEQUENCE; EXON; GENE AMPLIFICATION; GENE MUTATION; GENETIC ANALYSIS; HUMAN; HUMAN CELL; HYPERLIPOPROTEINEMIA TYPE 1; HYPERTRIGLYCERIDEMIA; MALE; PANCREATITIS; POLYMERASE CHAIN REACTION; PROMOTER REGION; PROTEIN VARIANT; XANTHOMA;

EID: 0031803628     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1093/clinchem/44.7.1388     Document Type: Article

References (55)

1. Hospattankar AV, Fairwell T, Ronan R, Brewer HB Jr. Amino acid sequence of human plasma apolipoprotein CII from normal and hyperlipoproteinemic subjects. J Biol Chem 1984;259:318-22.
2. Wu AL, Windmueller HG. Relative contributions by liver and intestine to individual plasma apolipoproteins in the rat. J Biol Chem 1979;254:7316-22.
3. Brewer HB Jr, Gregg RE, Hoeg JM, Fojo SS. Apolipoproteins and lipoproteins in human plasma: an overview [Review]. Clin Chem 1988;34:B4-8.
4. Hoffmann MM, Stoffel W. Construction and functional characterization of recombinant fusion proteins of human lipoprotein lipase and apolipoprotein CII. Eur J Biochem 1996;237:545-52.
5. Breckenridge WC, Alaupovic P, Cox DW, Little JA. Apolipoprotein and lipoprotein concentrations in familial apolipoprotein CII deficiency. Atherosclerosis 1982;44:223-35.
6. Brunzell JD. Familial lipoprotein lipase deficiency and other causes of the chylomicronemia syndrome. In: Scriver CR, Beaudet AL, Sly WS, Valle D, eds. The metabolic basis of inherited diseases. New York: McGraw-Hill, 1989:1165-80.
7. Gabelli C, Bilato C, Santamarina-Fojo S, Martini S, Brewer HB Jr, Crepaldi G, Baggio G. Heterozygous apolipoprotein CII deficiency: lipoprotein and apoprotein phenotype and Rsal restriction enzyme polymorphism in the apo CII-Padova kindred. Eur J Clin Invest 1993;23:522-8.
8. Catapano AL, Mills GL, Roma P, La Rosa M, Capurso A. Plasma lipids lipoproteins and apoproteins in a case of apo CII deficiency. Clin Chim Acta 1983;130:317-27.
9. Shachter NS, Hayek T, Leff T, Smith JD, Rosenberg DW, Walsh A, et al. Overexpression of apolipoprotein CII causes hypertriglyceridemia in transgenic mice. J Clin Invest 1994;93:1683-90.
10. Fojo SS, Law SW, Brewer HB Jr. The human preproapolipoprotein CII gene. Complete nucleic acid sequence and genomic organization. FEBS Lett 1987;213:221-6.
11. Connelly PW, Maguire GF, Hofmann T, Little JA. Structure of apolipoprotein CII-Toronto, a nonfunctional human apolipoprotein. Proc Natl Acad Sci U S A 1987;84:270-3.
12. Connelly PW, Maguire GF, Little JA. Apolipoprotein CII-St. Michael. Familial apolipoprotein CII deficiency associated with premature vascular disease. J Clin Invest 1987;80:1597-606.
13. Crecchio C, Capurso A, Pepe G. Identification of the mutation responsible for a case of plasmatic apolipoprotein CII deficiency (Apo CII-Bari). Biochem Biophys Res Commun 1990;168:1118-27.
14. Fojo SS, Beisiegel U, Beil U, Higuchi K, Bojanovski M, Gregg RE, et al. Donor splice site mutation in the apolipoprotein (Apo) CII gene (Apo CII-Hamburg) of a patient with Apo CII deficiency. J Clin Invest 1988;82:1489-94.
15. Fojo SS, Stalenhoef AF, Marr K, Gregg RE, Ross RS, Brewer HB Jr. A deletion mutation in the apo CII gene (apo CII-Nijmegen) of a patient with a deficiency of apolipoprotein CII. J Biol Chem 1988;263:17913-6.
16. Fojo SS, de Gennes JL, Chapman J, Parrott C, Lohse P, Kwan SS, et al. An initiation codon mutation in the apo CII gene (apo CII-Paris) of a patient with a deficiency of apolipoprotein CII. J Biol Chem 1989;264:20839-42.
17. Zanelli T, Catapano AL, Averna MR, Barbagallo CM, Liotta A, Giardina FC, Notarbartolo A. A new case of apo CII deficiency with a nonsense mutation in the apo CII gene. Clin Chim Acta 1994;224:111-8.
18. 10 → Thr) identified in patients with hyperlipidemia. Dis Markers 1991;9: 73-80.
19. 26 → Arg) in exon 3 of the apolipoprotein CII gene in a patient with apolipoprotein CII deficiency (apo CII-Wakayama). Biochem Biophys Res Commun 1993; 193:1174-83.
20. Pullinger CR, ZySow BR, Hennessy LK, Frost PH, Malloy MJ, Kane JP. Molecular cloning and characteristics of a new apolipoprotein CII mutant identified in three unrelated individuals with hypercholesterolemia and hypertriglyceridemia. Hum Mol Genet 1993;2: 69-74.
21. Xiong WJ, Li WH, Posner I, Yamamura T, Yamamoto A, Gotto AM Jr, Chan L. No severe bottleneck during human evolution: evidence from two apolipoprotein CII deficiency alleles. Am J Hum Genet 1991;48:383-9.
22. Streicher R, Geisel J, Weisshaar C, Avci H, Oette K, Müller-Wieland D. A single nucleotide substitution in the promoter region of the apolipoprotein CII gene identified in individuals with chylomicronemia. J Lipid Res 1996;37:2599-607.
23. März W, Schenk G, Gross W. Apolipoproteins CII, CIII in serum quantified by zone immunoelectrophoresis assay. Clin Chem 1987;33:664-9.
24. Baumstark MW, Berg A, Halle M, Keul J. Isoelectric focusing of apolipoproteins in immobilized pH gradients: improved determination of apolipoprotein E phenotypes. Electrophoresis 1988;9: 576-9.
25. März W, Cezanne S, Gross W. Immunoblotting of apolipoprotein E in immobilized pH gradients. Electrophoresis 1991;12:59-63.
26. Fischer SG, Lerman LS. Separation of random fragments of DNA according to properties of their sequences. Proc Natl Acad Sei U S A 1980;77:4420-4.
27. Chen M, März W, Manfras BJ, Kühnl P, Usadel KH, Böhm BO. Rapid and simple subtyping of the HLA-DRB3 gene in Graves' disease using temperature gradient gel electrophoresis. Hum Immunol 1993;36:199-203.
28. Chen M, März W, Usadel K, Scheurmann E, Böhm BO. Typing of the HLA-DRB3 gene by temperature gradient gel electrophoresis: prediction of the resolution of four allelic fragments by computational simulation of DNA melting. J Immunol Meth 1994;168: 257-65.
29. 112 → Arg) by polymerase chain reaction, restriction isotyping and temperature gradient gel electrophoresis. Electrophoresis 1993;14:1032-7.
30. Havel RJ, Eder HA, Bragdon JH. The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J Clin Invest 1955;34:1345-53.
31. Lindgren FT. Preparative ultracentrifuge laboratory procedures and suggestions for lipoprotein analysis. In: Perkins EG, ed. Analysis of lipids and lipoproteins. Champaign, IL: Am Oil Chem Soc, 1975:204-24.
32. Wanner D, Hörl WH, Luley CH, Wieland H. Effect of HMG-CoA reductase inhibitors in hypercholesterolemic patients on hemodialysis. Kidney Int 1991;31:754-9.
33. Das HK, Jackson CL, Miller DA, Leff T, Breslow JL. The human apolipoprotein CII gene sequence contains a novel chromosome 19-specific minisatellite in its third intron. J Biol Chem 1987;262: 4787-93.
34. Lerman LS, Silverstein K. Computational simulation of DNA melting and its application to denaturing gradient gel electrophoresis. Methods Enzymol 1987;155:482-501.
35. Nissen H, Guldberg P, Hansen AB, Petersen NE, Horder M. Clinically applicable mutation screening in familial hypercholesterolemia. Hum Mutat 1996;8:168-77.
36. Maguire GF, Little JA, Kakis G, Breckenridge WC. Apolipoprotein CII deficiency associated with nonfunctional mutant forms of apolipoprotein CII. Can J Biochem Cell Biol 1984;62:847-52.
37. Cotton RG, Rodrigues NR, Campbell RD. Reactivity of cytosine and thymine in single-base-pair mismatches with hydroxylamine and osmium tetroxide and its application to the study of mutations. Proc Natl Acad Sci U S A 1988;85:4397-401.
38. Myers RM, Larin Z, Maniatis T. Detection of single base substitutions by ribonuclease cleavage at mismatches in RNA:DNA duplexes. Science 1985;230:1242-6.
39. Keen J, Lester D, Inglehearn C, Curtis A, Bhattacharya S. Rapid detection of single base mismatches as heteroduplexes on Hydrolink gels. Trends Genet 1991;7:5.
40. White MB, Carvalho M, Derse D, O'Brien SJ, Dean M. Detecting single base substitutions as heteroduplex polymorphisms. Genomics 1992;12:301-6.
41. Grompe M. The rapid detection of unknown mutations in nucleic acids [Review]. Nat Genet 1993;5:111-7.
42. Nollau P, Wagener C. Methods for detection of point mutations-performance and quality assessment [Review]. Clin Chem 1997; 43:1114-28.
43. Spinardi L, Mazars R, Theillet C. Protocols for an improved detectior of point mutations by SSCP. Nucleic Acids Res 1991; 19:4009.
44. Lombardi P, Sijbrands EJ, van de Giessen K, Smelt AH, Kastelein JJ, Frants RR, Havekes LM. Mutations in the low density lipoprotein receptor gene of familial hypercholesterolemic patients detected by denaturing gradient gel electrophoresis and direct sequencing. J Lipid Res 1995;36:860-7.
45. Ekstrom U, Abrahamson M, Sveger T, Lombardi P, Nilsson-Ehle P. An efficient screening procedure detecting six novel mutations in the LDL receptor gene in Swedish children with hypercholesterolemia. Hum Genet 1995;96:147-50.
46. Nissen H, Hansen PS, Faergeman O, Horder M. Mutation screening of the codon 3500 region of the apolipoprotein B gene by denaturing gradient-gel electrophoresis. Clin Chem 1995;41: 419-23.
47. van den Maagdenberg AM, Weng W, de Bruijn IH, de Knijff P, Funke H, Smelt AHM, et al. Characterization of five new mutants in the carboxyl-terminal domain of human apolipoprotein E: no cosegregation with severe hyperlipidemia. Am J Hum Genet 1993;52:937-46.
48. Parker S, Angelico MC, Laffel L, Krolewski AS. Application of denaturing gradient gel electrophoresis to detect DNA sequence differences encoding apolipoprotein E isoforms. Genomics 1993; 16:245-7.
49. 291 → Ser) contributes to the expression of familial combined hyperlipidemia. Hum Mol Genet 1995;4: 1543-9.
50. Moyret C, Theillet C, Puig PL, Moles JP, Thomas G, Hamelin R. Relative efficiency of denaturing gradient gel electrophoresis and single strand conformation polymorphism in the detection of mutations in exons 5 to 8 of the p53 gene. Oncogene 1994;9: 1739-43.
51. Sheffield VC, Beck JS, Kwitek AE, Sandstrom DW, Stone EM. The sensitivity of single-strand conformation polymorphism analysis for the detection of single base substitutions. Genomics 1993; 16:325-32.
52. Guldberg P, Henriksen KF, Guttler F. Molecular analysis of phenylketonuria in Denmark: 99% of the mutations detected by denaturing gradient gel electrophoresis. Genomics 1993;17: 141-6.
53. Tartary M, Vidaud D, Piao Y, Costa JM, Bahnak BR, Fressinaud E, et al. Detection of a molecular defect in 40 of 44 patients with haemophilia B by PCR and denaturing gradient gel electrophoresis. Br J Haematol 1993;84:662-9.
54. Nissen H, Petersen NE, Mustajoki S, Hansen TS, Mustajoki P, Kauppinen R, Horder M. Diagnostic strategy, genetic diagnosis and identification of new mutations in intermittent porphyria by denaturing gradient gel electrophoresis. Hum Mutat 1997;9:122-30.
55. Hegele RA, Tu L. Variation within intron 3 of the apolipoprotein CII gene. Nucleic Acids Res 1991;19:3162.-